Clinical Pharmacokinetics

3.9(top 10%)

impact factor

3.4K(top 5%)

papers

222.6K(top 2%)

citations

208(top 1%)

h-index

4.1(top 10%)

impact factor

3.7K

all documents

231.7K

doc citations

303(top 2%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Pharmacokinetics of Pegylated Liposomal Doxorubicin	Clinical Pharmacokinetics	2003	1,339
2	Pharmacokinetics and Pharmacodynamics of Cannabinoids	Clinical Pharmacokinetics	2003	1,100
3	Understanding the Dose-Effect Relationship	Clinical Pharmacokinetics	1981	994
4	Clinical Pharmacology of Tramadol	Clinical Pharmacokinetics	2004	969
5	Clinical Pharmacokinetics of Metformin	Clinical Pharmacokinetics	2011	910
6	Clinical Pharmacology of 5-Fluorouracil	Clinical Pharmacokinetics	1989	777
7	Pegylation	Clinical Pharmacokinetics	2001	775
8	Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism	Clinical Pharmacokinetics	2002	771
9	Role of P-Glycoprotein in Pharmacokinetics	Clinical Pharmacokinetics	2003	757
10	Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition	Clinical Pharmacokinetics	2000	750
11	Clinical Pharmacokinetics of Mycophenolate Mofetil	Clinical Pharmacokinetics	1998	738
12	Sex Differences in Pharmacokinetics and Pharmacodynamics	Clinical Pharmacokinetics	2009	724
13	Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation	Clinical Pharmacokinetics	2004	708
14	Quantification of Lean Bodyweight	Clinical Pharmacokinetics	2005	707
15	Inhibition and Induction of Cytochrome P450 and the Clinical Implications	Clinical Pharmacokinetics	1998	674
16	Clinical Pharmacokinetics of Tacrolimus	Clinical Pharmacokinetics	1995	671
17	Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate	Clinical Pharmacokinetics	2010	659
18	Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids	Clinical Pharmacokinetics	2005	655
19	Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections	Clinical Pharmacokinetics	2004	644
20	Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions	Clinical Pharmacokinetics	1997	641
21	Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine	Clinical Pharmacokinetics	2017	639
22	Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance	Clinical Pharmacokinetics	2009	604
23	Effect of Obesity on the Pharmacokinetics of Drugs in Humans	Clinical Pharmacokinetics	2010	594
24	Pharmacokinetic Interactions with Rifampicin	Clinical Pharmacokinetics	2003	591
25	Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies	Clinical Pharmacokinetics	2010	564
26	Drug Interactions with Tobacco Smoking	Clinical Pharmacokinetics	1999	562
27	Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate	Clinical Pharmacokinetics	2008	562
28	Clinical Pharmacokinetics of Imatinib	Clinical Pharmacokinetics	2005	546
29	Pregnancy-Induced Changes in Pharmacokinetics	Clinical Pharmacokinetics	2005	538
30	Effects of Obesity on Pharmacokinetics	Clinical Pharmacokinetics	2000	526
31	Enterohepatic Circulation	Clinical Pharmacokinetics	2002	521
32	Clinical Pharmacokinetics of Metformin	Clinical Pharmacokinetics	1996	512
33	Interindividual Variability of the Clinical Pharmacokinetics of Methadone	Clinical Pharmacokinetics	2002	510
34	Pharmacological Effects of Formulation Vehicles	Clinical Pharmacokinetics	2003	510
35	Drug Transfer and Metabolism by the Human Placenta	Clinical Pharmacokinetics	2004	501
36	Clinical Pharmacokinetics of Atorvastatin	Clinical Pharmacokinetics	2003	482
37	A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin	Clinical Pharmacokinetics	2010	482
38	Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients	Clinical Pharmacokinetics	2007	481
39	Cytochrome P450 3A	Clinical Pharmacokinetics	1999	480
40	Effects of the Antifungal Agents on Oxidative Drug Metabolism	Clinical Pharmacokinetics	2000	471
41	The Gut as a Barrier to Drug Absorption	Clinical Pharmacokinetics	2001	468
42	Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development	Clinical Pharmacokinetics	2009	466
43	Olanzapine	Clinical Pharmacokinetics	1999	460
44	Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors	Clinical Pharmacokinetics	1997	447
45	Clinical Pharmacokinetics of Diazepam	Clinical Pharmacokinetics	1978	439
46	Clinical Pharmacokinetics of Theophylline	Clinical Pharmacokinetics	1978	438
47	Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children	Clinical Pharmacokinetics	2006	437
48	Pharmacokinetics and Clinical Effectiveness of Methylphenidate	Clinical Pharmacokinetics	1999	436
49	Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration	Clinical Pharmacokinetics	1999	432
50	Clinical Pharmacokinetics of Cyclosporin	Clinical Pharmacokinetics	1986	431

Scientometrics

Overviews

Citing Bodies

Clinical Pharmacokinetics

Top Articles